| WHO - Prequalification of Medical Products (IVDs, Medicines, Vaccines and Immunization Devices, Vector Control)

13th Invitation for Expression of Interest (EOI) for Active Pharmaceutical Ingredients (APIs) for prequalification

M

Announcement

15 February, 2017 - 01:00 (CET)

The following active pharmaceutical ingredients (APIs) were added:

Azithromycin
Miltefosine
Paromomycin
Sodium stibogluconate (SB⁵⁺)

New WHO Public Assessment Reports (WHOPARs) published

M

Medicine Update

7 February, 2017 - 01:00 (CET)

The Medicines Patent Pool Announces First Licence for Tuberculosis Treatment

M

Announcement

25 January, 2017 - 01:00 (CET)

The Medicines Patent Pool today announced that it has signed a licence w

New WHO Public Inspection Reports (WHOPIRs) published

M

Alerts

20 January, 2017 - 01:00 (CET)

Caribbean Community (CARICOM) joins the collaborative registration procedure

M

Announcement

10 January, 2017 - 01:00 (CET)

See: NMRAs participating in the WHO collaborative proced

New WHO Public Assessment Reports (WHOPARs) published

M

Medicine Update

6 January, 2017 - 01:00 (CET)

8th Invitation for Expression of Interest (EOI) to manufacturers of Reproductive Health products

M

Alerts

22 December, 2016 - 01:00 (CET)

The following products were added:

Treatment of maternal syphilis and prevention of congenital syphilis

Adult formulations

Newly Prequalified Active Pharmaceutical Ingredient (API)

M

Alerts

22 December, 2016 - 01:00 (CET)

Medroxyprogesterone manufactured by Taizhou Taifa Pharmaceutical Co Ltd has been prequalified by the WHO Prequalification Team: medicines (PQTm) under its API prequalification procedure.

Newly prequalified Quality Control Laboratory (QCL)

M

Alerts

22 December, 2016 - 01:00 (CET)

New addition to the List of Prequalified Quality Control Laboratories (QCL):

8 products newly prequalified

M

Medicine Update

21 December, 2016 - 01:00 (CET)

WHO Prequalification Team - Medicines (PQT) added the below new products to its prequalified list

Subscribe to